demonstrated that intraperitoneal injection of osteocalcin significantly protected wild-type mice from obesity and NAFLD, but not liver-specific GPRC6A knockout mice, suggesting that GPRC6A mediated the ability of osteocalcin to inhibit lipid synthesis and promote lipolysis (35). Here, BGLAP is linked to obesity due to melanocortin 4 receptor deficiency.